文献速递关节外科创伤骨科

假体周围感染两阶段治疗中肾损伤与死亡率极低

Kidney Injury and Mortality Are Minimal Following Two-Stage Treatment of Periprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2026-06-16

该回顾性研究纳入138例接受两阶段翻修的髋/膝关节假体周围感染患者,采用标准化围手术期方案(含控制性降压、氨甲环酸、积极液体复苏及6周静脉抗生素)。结果显示急性肾损伤发生率为9.4%(无基础肾病者4.3%),各阶段肾功能指标无显著差异,90天死亡率0%,1年死亡率1.4%,两例死亡均与肾功能无关。

要点

  • 标准化方案下两阶段翻修PJI的急性肾损伤发生率为9.4%,无基础肾病患者仅4.3%。
  • 切除前、间期及再植入后平均肌酐、eGFR及尿素氮无显著差异(P≥0.432)。
  • 90天死亡率为0%,1年死亡率1.4%,两例死亡均为心脏事件且与肾功能无关。

核心结论

  • 在采用标准化围手术期方案的单中心系列中,两阶段治疗PJI期间平均肾功能指标保持相对稳定。
  • 两阶段治疗后的死亡率可忽略不计,且不太可能与治疗本身相关。
  • 仍需要开展与一期技术相比较的研究。

研究设计与样本

  • 回顾性综述了138例因PJI接受两阶段治疗的髋和膝关节临床数据。
  • 所有患者均采用标准化围手术期临床方案,包括控制性降压和氨甲环酸以减少术中失血、积极液体复苏、内科优化以及再植入前六周静脉抗生素。
  • 从全州医疗系统收集急性肾损伤发生率、血清肌酐、估算肾小球滤过率、血尿素氮及总死亡率。
  • P值≤0.05认为有统计学意义。
  • 证据等级为III级。

主要发现

  • 急性肾损伤总体发生率为9.4%(13/138),无基础肾病患者中为4.3%。
  • 切除前、间期及再植入后平均血清肌酐分别为1.10、1.12、1.13 mg/dL,无显著差异(P≥0.432;把握度≥85.3%)。
  • 切除前、间期及再植入后平均估算肾小球滤过率分别为78.6、77.7、74.8 mL/minute/1.73 m2,无显著差异(P≥0.432;把握度≥85.3%)。
  • 切除前、间期及再植入后平均血尿素氮分别为19.8、18.9、19.0 mg/dL,无显著差异(P≥0.432;把握度≥85.3%)。
  • 切除后90天内死亡率为零,切除后一年内死亡率为1.4%(2/138),两例死亡均为与肾功能无关的心脏事件;Kaplan-Meier生存估计为切除后两年98%、五年86%。

临床怎么用

  • 对于慢性PJI患者,采用包含控制性降压、氨甲环酸、积极液体复苏及六周静脉抗生素的标准化方案行两阶段翻修,肾功能指标可保持稳定且死亡率极低。

局限性

  • 本研究为单中心回顾性系列。
  • 仍需要开展与一期技术相比较的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current gold standard treatment for chronic periprosthetic joint infection (PJI) is a two-stage surgery with antibiotics between implant resection and reimplantation. Recently, claims have been reported of nephrotoxic antibiotic exposure and acute kidney injury (AKI) during the two-stage PJI treatment. This study evaluated kidney function and mortality before, during, and after two-stage revisions for PJI using a standardized protocol. METHODS: Clinical data from 138 hips and knees undergoing two-stage treatment for PJI were retrospectively reviewed. Standardized perioperative clinical protocols were used for all patients, including hypotensive anesthesia and tranexamic acid to minimize operative blood loss, aggressive fluid resuscitation, medical optimization, and six weeks of intravenous antibiotics prior to reimplantation. The incidence of AKI, serum creatinine, estimated glomerular filtration rate, blood urea nitrogen, and overall mortality were collected from a statewide healthcare system. P-values ≤ 0.05 were considered statistically significant. RESULTS: Overall, the incidence of AKI was 9.4% (13 of 138), which was 4.3% in patients who did not have preexisting kidney disease. There were no significant differences observed in mean serum creatinine (1.10, 1.12, 1.13 mg/dL), estimated glomerular filtration rate (78.6, 77.7, 74.8 mL/minute/1.73 m2), or blood urea nitrogen levels (19.8, 18.9, 19.0 mg/dL) across the pre-resection, the interstage, and postreimplantation periods, respectively (P ≥ 0.432; power ≥ 85.3%). Mortality was zero within 90 days of resection and 1.4% (two of 138) within one year of resection; both deaths were due to cardiac events unrelated to kidney function. Kaplan-Meier survivorship estimates were 98% at two years and 86% at five years postresection. CONCLUSIONS: In this single-institution series using a standardized protocol, mean kidney function metrics remained relatively stable throughout the two-stage treatment. Furthermore, mortality after the two-stage approach was negligible and unlikely to be associated with the treatment itself. Still, comparative studies of the one-stage technique remain warranted. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Epley RL, Stoops TK, Deckard ER, et al. Kidney Injury and Mortality Are Minimal Following Two-Stage Treatment of Periprosthetic Joint Infection. J Arthroplasty. 2026. PMID: 42303006. doi:10.1016/j.arth.2026.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。